PRAGUE-17: LAA Closure Holds Up Against DOACs Out to 4 Years
Extended follow-up of the PRAGUE-17 trial suggests left atrial appendage closure (LAAC) remains noninferior to direct-acting oral anticoagulants (DOACs) with
Read moreExtended follow-up of the PRAGUE-17 trial suggests left atrial appendage closure (LAAC) remains noninferior to direct-acting oral anticoagulants (DOACs) with
Read morePhysical activity, long recommended by health experts to reduce risk for obesity, how many cycles of clomid before ivf heart
Read moreAdults younger than age 60 whose days are filled with sedentary leisure time (which includes using the computer, TV, or
Read moreA recent study published in the Mayo Clinic Proceedings by researchers at the University of Alabama at Birmingham shows the
Read moreIn patients with intermediate risk of atherosclerotic cardiovascular disease along with risk-enhancing factors, coronary artery calcium scoring may help more
Read moreSumanth D. Prabhu, MD, an internationally recognized expert in how immunity and inflammation contribute to heart failure, has been named
Read moreMidlife changes in wealth may affect a patient’s risk of cardiovascular disease, a new cohort study suggests. It found that
Read moreThe optimal first step to address mild to moderately elevated blood pressure and cholesterol in otherwise healthy adults is a
Read moreTaking more steps each day, in short spurts or longer bouts, was associated with a longer life in women older
Read moreTransradial vascular access is often preferred over the transfemoral route in percutaneous coronary intervention (PCI) for its lower associated risks
Read more